Related Experiment Video
Updated: Mar 1, 2026
A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
Novel and Experimental Therapies in Chronic Pancreatitis
Soumya Jagannath1, Pramod Kumar Garg2
1Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Abstract:
Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas. The currently available treatment of CP is aimed at controlling symptoms and managing complications. Unfortunately, no specific treatment is available to halt the progression of the disease process because the pathophysiological perturbations in CP are not well understood. In this review, we discuss various therapeutic targets and investigational agents acting on these targets. Among these, therapies modulating immune cells and those acting on pancreatic stellate cells appear promising and may translate into clinical benefit in near future. However, these experimental therapies are mostly in animal models and they do not recapitulate all aspects of human disease. Still they may be beneficial in developing effective therapeutic modalities to curb inflammation in chronic pancreatitis.
Insights
Chronic pancreatitis (CP) treatments focus on symptoms, not disease progression. New therapies targeting immune cells and pancreatic stellate cells show promise for curbing inflammation in CP.
Area of Science:
- Gastroenterology
- Immunology
- Cell Biology
Background:
- Chronic pancreatitis (CP) is a progressive inflammatory pancreatic disease.
- Current treatments manage symptoms and complications but do not halt disease progression.
- The underlying pathophysiology of CP remains incompletely understood, hindering specific treatment development.
Purpose of the Study:
- To review current and investigational therapeutic targets for chronic pancreatitis.
- To highlight promising agents that may halt CP progression.
- To discuss the potential clinical translation of novel CP therapies.
Main Methods:
- Literature review of existing research on chronic pancreatitis.
- Analysis of therapeutic targets and investigational agents.
- Evaluation of preclinical data for novel treatment modalities.
Main Results:
- Several therapeutic targets and agents are under investigation for CP.
- Modulating immune cells and targeting pancreatic stellate cells show potential.
- Experimental therapies, primarily in animal models, offer insights into curbing pancreatic inflammation.
Conclusions:
- Effective treatments to halt chronic pancreatitis progression are lacking.
- Targeting immune cells and pancreatic stellate cells represents a promising therapeutic avenue.
- Further research, despite limitations of animal models, may lead to effective anti-inflammatory strategies for CP.
More Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include: